Anti-relapse neurons in the infralimbic cortex of rats drive relapse-suppression by drug omission cues by Laque, Amanda et al.
Anti­relapse neurons in the infralimbic cortex of rats drive 
relapse­suppression by drug omission cues
Article  (Published Version)
http://sro.sussex.ac.uk
Laque, Amanda, De Ness, Genna, Wagner, Grant E, Nedelescu, Hermina, Carroll, Ayla, Watry, 
Debbie, Kerr, Tony, Koya, Eisuke, Hope, Bruce T, Weiss, Friedbert, Elmer, Greg I and Suto, 
Nobuyoshi (2019) Anti-relapse neurons in the infralimbic cortex of rats drive relapse-suppression 
by drug omission cues. Nature Communications, 10. a3934. ISSN 2041-1723 
This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/85280/
This document is made available in accordance with publisher policies and may differ from the 
published  version or from the version of record. If you wish to cite this item you are advised to 
consult the publisher’s version. Please see the URL above for details on accessing the published 
version. 
Copyright and reuse: 
Sussex Research Online is a digital repository of the research output of the University.
Copyright and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable, the material 
made available in SRO has been checked for eligibility before being made available. 
Copies of full text items generally can be reproduced, displayed or performed and given to third 
parties in any format or medium for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge, provided that the authors, title and full bibliographic 
details are credited, a hyperlink and/or URL is given for the original metadata page and the 
content is not changed in any way. 
ARTICLE
Anti-relapse neurons in the infralimbic cortex of
rats drive relapse-suppression by drug omission
cues
Amanda Laque1, Genna L. De Ness 1, Grant E. Wagner 1, Hermina Nedelescu 1, Ayla Carroll 1,
Debbie Watry1, Tony M. Kerr 1, Eisuke Koya 2, Bruce T. Hope 3, Friedbert Weiss 1, Greg I. Elmer 4 &
Nobuyoshi Suto 1
Drug addiction is a chronic relapsing disorder of compulsive drug use. Studies of the neu-
robehavioral factors that promote drug relapse have yet to produce an effective treatment.
Here we take a different approach and examine the factors that suppress—rather than
promote—relapse. Adapting Pavlovian procedures to suppress operant drug response, we
determined the anti-relapse action of environmental cues that signal drug omission (una-
vailability) in rats. Under laboratory conditions linked to compulsive drug use and heightened
relapse risk, drug omission cues suppressed three major modes of relapse-promotion (drug-
predictive cues, stress, and drug exposure) for cocaine and alcohol. This relapse-suppression
is, in part, driven by omission cue-reactive neurons, which constitute small subsets of glu-
tamatergic and GABAergic cells, in the infralimbic cortex. Future studies of such neural
activity-based cellular units (neuronal ensembles/memory engram cells) for relapse-
suppression can be used to identify alternate targets for addiction medicine through func-
tional characterization of anti-relapse mechanisms.
https://doi.org/10.1038/s41467-019-11799-1 OPEN
1 Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037, USA. 2 Sussex Neuroscience, School of Psychology, University of Sussex,
Falmer, UK. 3 Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, NIH/DHHS, Baltimore, MD, USA. 4Maryland
Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA. Correspondence and
requests for materials should be addressed to F.W. (email: bweiss@scripps.edu) or to G.I.E. (email: gelmer@som.umaryland.edu)
or to N.S. (email: nsuto@scripps.edu)
NATURE COMMUNICATIONS |         (2019) 10:3934 | https://doi.org/10.1038/s41467-019-11799-1 | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
Relapse prevention is a major goal in the treatment of drugaddiction1, as many addicts return to compulsive drug useeven after a successful period of abstinence2. A signiﬁcant
amount of research has been, therefore, dedicated to determining
the neurobehavioral factors that promote drug relapse. Environ-
mental cues predictive of drug availability, along with stress and
the drug itself, are recognized as key relapse-promoting factors
due to their enduring ability to trigger craving in recovering
addicts and reinstate extinguished drug seeking in laboratory
animals3. A wealth of knowledge is now available describing how
these factors engage distinct brain processes to promote relapse4.
Unfortunately, anti-relapse medications designed to counter
relapse-promoting brain processes have been met with limited
clinical success5,6. Psychosocial interventions designed to counter
relapse-promoting environmental cues, such as cue-exposure
therapy, have also been met with limited success7. Hence, an
alternative research strategy may prove beneﬁcial.
Based on this premise, we aimed to determine the neurobe-
havioral factors that suppress—rather than promote—drug
relapse and developed an omission cue-induced suppression
(OCIS) procedure to serve as an animal model of relapse-
suppression. Adapting Pavlovian procedures for response inhi-
bition, such as “conditioned inhibition”8 and “negative occasion
setting”9, we used a discriminative stimulus predictive of drug
omission (unavailability) to suppress operant drug seeking in rats.
The overall goal was twofold: (1) to extend previous studies,
which took similar approaches, e.g., refs. 10–17, under transla-
tionally relevant laboratory conditions linked to drug addiction
states and relapse risk, and (2) to establish the causality between
omission cue-induced brain process and relapse-suppression in a
straightforward manner.
In the present study, we tested two versions of the OCIS
procedure, each unique to a speciﬁc addiction-linked condition in
male rats. The ﬁrst version was for rats with regular access to
cocaine over a prolonged period—a condition linked to com-
pulsive drug use18,19. The second version was for alcohol
dependent rats undergoing acute or protracted withdrawal—
conditions linked to heightened relapse risk20,21. We ﬁrst utilized
the OCIS procedure to determine the anti-relapse action of drug-
omission cues against the three major modes of relapse-
promotion (drug-predictive “availability” cues, stress, and drug
itself) across two major classes of abused drugs (cocaine and
alcohol). We then utilized the OCIS procedure as the behavioral
platform to determine the brain processes that actively suppress
relapse.
We previously reported22,23 that two distinct units of neurons,
both localized within the infralimbic cortex (IL; the ventral part of
the medial prefrontal cortex), exert opposing environmental
actions (promotion and suppression) on appetitive behavior
towards non-drug rewards (glucose and saccharin). Similar
functional units of prefrontal cortical neurons have been
reported24,25. Given that the medial prefrontal cortex is impli-
cated in decision making and impulse control in general26,27, we
hypothesized that drug-omission cues recruit (activate), in a
similar manner, such functional units of neurons (“neural
ensembles”28 and/or “memory engram cells”29) to suppress
relapse. We therefore ﬁrst determined omission cue-induced
neural activity in IL, using immunohistochemistry (IHC), to
identify neurons reactive to cocaine or alcohol omission cues (as
marked by the molecular activation marker Fos). We then
characterized the phenotypic composition of these omission “cue-
reactive” neurons in IL, using multiplex in situ hybridization
(RNAscope®), to determine the extent of omission cue-induced
neural activity across three major neural phenotypes (glutama-
tergic30, GABAergic31 and cholinergic32 cells) of the medial
prefrontal cortex.
Contradictory reports exist regarding medial prefrontal
cortical regulation of drug relapse33,34. Disrupting neural
activity in IL, using inhibitory GABA agonists, interferes not
only with extinction (suppression)12,35,36 (also see ref. 14), but
also with reinstatement (promotion)37,38 of drug seeking. Yet
other reports indicate that GABA agonists in IL do not produce
a signiﬁcant effect on drug seeking11,39 (also see ref. 40). We
hypothesized that these mixed results were due to the fact that
GABA agonists would have inhibited local cells irrespective of
their intrinsic activity. Such neural activity, in response to
behaviorally relevant stimuli, is thought to represent a unique
learned association between stimuli (Pavlovian conditioning)
and/or between a behavioral response and a consequence
(operant conditioning)28,29. Non-activity-speciﬁc inhibition of
IL neurons by GABA agonists likely affects multiple learned
associations at once, and it would thereby result in complex
behavioral responses that are potentially not relevant to the
control of drug seeking and relapse. To overcome this technical
issue, we utilized a neural activity-based ablation technique
(Daun02 disruption41) to selectively disrupt drug-omission
cue-reactive neurons in IL, thus unambiguously establishing the
causality between omission cue-induced neural activity and
relapse-suppression.
We report here that drug-omission cues can be used to sup-
press three major modes of relapse-promotion (drug-predictive
cues, stress, and drug exposure) across two major classes of
abused drugs (cocaine and alcohol) in male rats. Omission cue-
reactive neurons in IL, which constitute small subsets of gluta-
matergic and GABAergic cells, drive this relapse-suppression.
Further characterization of such anti-relapse neurons and brain
mechanisms can guide the identiﬁcation of alternate targets for
addiction medicine.
Results
Relapse-suppression by cocaine omission cues. Rats underwent
the OCIS procedure for cocaine seeking (Fig. 1a). All rats were
ﬁrst trained (Fig. 1b: Self-administration training) to press an
“active lever” for an intravenous cocaine infusion (1.0 mg/kg)
presented together with a light-cue. Both active lever and light-
cue thus came to predict cocaine as “cocaine availability cues”.
Rats quickly learned to dissociate between the active lever and an
identical but “inactive” lever. The rats were then trained (Fig. 1c:
Discrimination training) to recognize an olfactory cue (orange
scent) as a discriminative stimulus predictive of cocaine omission
(“cocaine S-”). For this, each rat repeatedly underwent two types
of once daily cue-training (“No S-” and “S-”) sessions over a
prolonged period. Inactive lever-pressing remained minimal
during both S- and No S- training (Supplementary Fig. 1a).
The results from additional groups of rats (Fig. 1d) conﬁrmed
that, consistent with previous reports18,19, prolonged access to
cocaine resulted in punishment-resistant “compulsive” cocaine
intake. Here, we determined animals’ resistance to cocaine-paired
punishment after the Self-administration training and Discrimi-
nation training phases. Compulsivity was measured as the
percentage of numbers of self-administered cocaine, each paired
with electric foot-shock, against numbers of self-administered
cocaine under the baseline (no shock) condition. Compared to
the rats with limited (2–3 weeks) access to cocaine through Self-
administration training, the rats with additional (9+weeks)
access through Discrimination training were signiﬁcantly more
resistant to electric foot-shock (0.8 mA, 1-s) paired with each
delivery of self-administered cocaine.
The rats were then tested for relapse-suppression by cocaine S-
(Discrimination tests). For this, each rat underwent two types
(“No S-” and “S-”) of cue-tests. Each cue-test (6 h, total) was
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divided into three 2-h blocks. Under both No S- and S-
conditions, cocaine was not available for self-administration.
Relapse-suppression against cocaine availability cues (active lever
and light-cue) was determined in all rats during the ﬁrst 2-h
block. Relapse-suppression against cocaine and stress priming
was determined in different groups of rats during the second and
third 2-h blocks.
Despite the extensive drug history linked to compulsive cocaine
intake18,19 (Fig. 1d), cocaine S- suppressed the relapse-promoting
action of cocaine availability cues (Fig. 1e). During the ﬁrst 2-h
block of the No S- test, the rats initiated and maintained active
lever-pressing, even though this behavior only resulted in the
light-cue but not cocaine. In contrast, during the S- test, the same
rats minimally lever-pressed under otherwise identical stimulus
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Fig. 1 Omission cue-induced suppression (OCIS) procedure for cocaine seeking. A total of 63 rats were initially used and randomly assigned to four
experimental groups: Compulsivity test, Cocaine (1.0 or 2.0 mg/kg), and Stress priming groups (n= 14,16,16,17). Of which, 45 rats were retained for
statistical analyses (see Methods). Final Ns for each group are described below. All data are mean and SEM. Gray open circles on bar charts depict
individual data-points. a Timeline and schedule. b Responses during the ﬁrst 14 days of Self-administration (SA) training. c Responses during the ﬁrst and
last 10 days of Discrimination training. d Compulsivity tests for animals’ resistance to cocaine-paired punishment after cocaine access through the SA
training phase vs. both SA and Discrimination training phases. Each cocaine infusion was paired with an electric foot-shock (0.8 mA, 1-s). n= 6,6. Student’s
t-test: t(10)= 3.20, *P < 0.05. e Responses during the ﬁrst 2-h block of Discrimination test to determine cocaine S-‘s action against cocaine availability cues
(active lever and light-cue). n= 33. Paired t-test: t(32)= 11.50, *P < 0.001. Duplicate data-points from multiple subjects are not overlaid on this Figure for
clarity because n= 33. Thus, these dot plots represent the data range. f, g Responses during the second and third 2 h-blocks of Discrimination test (within-
session reinstatement) to determine cocaine S-‘s action against cocaine priming (10 and 20mg/kg, IP). Two-way repeated measures ANOVA for the 10
mg/kg group (n= 12): Priming (F(1,11)= 19.20, P < 0.001) main effects and Cue-Test x Priming interaction (F(1,11)= 10.34, P < 0.01). Two-way repeated
measures ANOVA for the 20mg/kg group (n= 10): Cue-Test (F(1,9)= 42.02, P < 0.001) and Priming (F(1,9)= 47.19, P < 0.001) main effects, and Cue-Test
x Priming interaction (F(1,9)= 94.49, P < 0.001). †P < 0.001 vs. IP saline. *P < 0.01–0.05 vs. No S-. Tukey HSD test. h Responses during the second and third
2 h-blocks of Discrimination test to determine cocaine S-‘s action against stress priming (mild electric foot-shock, intermittent, 10 min, 0.8 mA). n= 11.
Two-way repeated measures ANOVA: Cue-Test (F(1,10)= 17.41, P < 0.01) and Priming (F(1,10)= 121.79, P < 0.001) main effects, and Cue-Test x Priming
interaction (F(1,10)= 15.36, P < 0.01). †P < 0.01 vs. sham foot-shock. *P < 0.05 vs. No S-. Tukey HSD test
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conditions. Thus, active lever and light-cue, as cocaine availability
cues, sufﬁciently (without the primary cocaine reward) promoted
operant drug response (cocaine seeking) in the absence (No S-)—
but not the presence (S-)—of cocaine omission cues. Inactive
lever-pressing remained minimal during both S- and No S- tests
(Supplementary Fig. 1b).
Cocaine S- also suppressed the relapse-promoting action of
cocaine (Fig. 1f, g) and stress (Fig. 1h) priming. During the No S-
test, active lever-pressing for the light-cue decreased over the
initial 2-h period of the 6-h test (within-session extinction).
Priming by saline (0.5 ml, IP) or sham shock—given at 2 h into
the 6-h test—minimally affected the then-extinguished lever-
pressing. In contrast, priming by cocaine (10 or 20 mg/kg, IP) or
electric foot-shock stress (0.8 mA for 0.5-s delivered over 10 min
on a variable time schedule at a mean interval of 40 s), adapted
from ref. 42 given 2 h later at 4 h into the 6-h test, signiﬁcantly
increased this cocaine-seeking behavior (within-session reinstate-
ment). However, during the S- test, cocaine or foot-shock priming
failed to reinstate the extinguished cocaine seeking. Inactive lever-
pressing remained minimal during both S- and No S- tests
(Supplementary Fig. 1c, d, e).
These results extend previous reports10,11,13,14,43 and establish
the anti-relapse action of cocaine omission cues.
Relapse-suppression by alcohol omission cues. Rats underwent
the OCIS procedure for alcohol (Fig. 2a). Each rat was tested for
relapse-suppression three times under different alcohol with-
drawal states: non-withdrawal (NW), acute withdrawal (AW),
and protracted withdrawal (PW). All rats were ﬁrst trained (Fig.
2b: self-administration training) to press an “active lever” for
alcohol (20%, v/v, oral) presented together with a “light-cue”.
Both active lever and light-cue thus came to predict alcohol as
“availability cues”. Rats quickly learned to dissociate between the
active lever and an identical but “inactive” lever. The rats were
then trained (Fig. 2c: Discrimination training NW) to recognize
an olfactory cue (orange scent) as a discriminative stimulus sig-
naling alcohol omission (“alcohol S-”). For this, each pre-
dependent rat repeatedly underwent two types of once daily cue-
training (“No S-” and “S-”) sessions. Inactive lever-pressing
remained minimal during both S- and No S- training (Supple-
mentary Fig. 2a).
The rats were then tested for relapse-suppression by alcohol S-
(Discrimination tests NW) before being subjected to an
experimental procedure to induce alcohol dependence (alcohol
liquid diet, adapted from refs. 43,45). The rats were further trained
(Fig. 2d) for alcohol S- during acute (5–8 h) withdrawal from
alcohol (Discrimination training AW). Alcohol liquid diet was
initially available continuously for 3 weeks, and then intermit-
tently (14 h daily) to induce AW. Operant training was resumed
3–4 days after this schedule change. Consistent with previous
reports44,45, AW from alcohol liquid diet resulted in a small but
signiﬁcant increase in operant responding for alcohol (Fig. 2c, d).
Similar alcohol diet schedules are known to produce somatic and
emotional withdrawal symptoms in rats46,47. The observed
increase in operant responding, evident from the initial No S-
(alcohol) sessions under AW (as in refs. 45,48), was thus
presumably because the rats had learned to alleviate such
symptoms by consuming alcohol (initially in alcohol liquid diet).
Inactive lever-pressing remained minimal during both S- and No
S- training while rats undergoing AW (Supplementary Fig. 2b).
Lastly, the rats were tested for relapse-suppression by alcohol S-
during acute (5–8 h) and protracted (2+weeks) withdrawal from
alcohol (Discrimination tests AW and PW).
During Discrimination tests NW, AW, and PW, each rat
underwent two types (“No S-” and “S-”) of cue-tests. Under both
No S- and S- conditions, alcohol was not available for self-
administration. Each cue-test (3 h, total) was divided into three 1-
h blocks. Relapse-suppression against alcohol availability cues
(active lever and light-cue) was determined in all rats during the
ﬁrst 1-h block. Relapse-suppression against alcohol and stress
priming was determined in different groups of rats during the
second and third 1-h blocks.
Consistent with previous reports, e.g., ref. 49, when primed by
alcohol availability cues, stress or alcohol, the rats pressed the
active lever signiﬁcantly more during Discrimination tests AW
and PW than NW (Fig. 2e, f, g). Such enhanced responding is
presumably due to alcohol withdrawal linked to heightened
relapse risk20,21, although it may also result from the additional
operant training for alcohol through Discrimination training
AW. Regardless of the mechanisms, alcohol S- suppressed the
relapse-promoting action of alcohol availability cues in rats
subjected to alcohol liquid diet (Fig. 2e). During the No S- test,
the rats engaged in active lever-pressing, even though this
behavior only resulted in the light-cue but not alcohol. In
contrast, during the S- test, the same rats minimally lever-pressed
under otherwise identical stimulus conditions (active lever and
light-cue but no alcohol). Thus, active lever and light cue, as
alcohol availability cues, sufﬁciently (without the primary
alcohol reward) promoted operant drug response (alcohol
seeking) in the absence (No S-)—but not the presence (S-)—of
alcohol omission cues. Inactive lever-pressing remained minimal
during both S- and No S- tests under the NW, AW, and PW
conditions (Supplementary Fig. 2c).
Furthermore, alcohol S- signiﬁcantly suppressed the relapse-
promoting action of alcohol (Fig. 2f) and stress (Fig. 2g) priming.
During the No S- test, active lever-pressing for light-cue
decreased over the initial 1-h period of the 3-h test (within-
session extinction). Priming by water (0.2 ml, oral) or saline (0.5
ml, IP)—given at 1 h into the 3-h test—minimally affected the
then-extinguished lever-pressing. In contrast, priming by alcohol
(20%, v/v, 0.2 ml, oral), adapted from ref. 50 or the pharmaco-
logical stressor yohimbine (0.75 mg/kg, IP), adapted from
ref. 51 given 1 h later at 2 h into the 3-h test, signiﬁcantly
increased this alcohol-seeking behavior (within-session reinstate-
ment). However, during the S- test, neither alcohol nor
yohimbine resulted in reinstatement. Inactive lever-pressing
remained minimal during both S- and No S- tests under the
NW, AW, and PW conditions (Supplementary Fig. 2d, e).
These results extend previous reports16,17 and establish the
anti-relapse action of alcohol omission cues. While the pharma-
cological action of alcohol and cocaine are different, as in the case
of the relapse-promoting cues, a similar learning mechanism thus
appears to mediate the environmental control of alcohol and
cocaine seeking.
Drug-omission cue-reactive neurons in the infralimbic cortex.
Two groups of rats were trained under the OCIS procedures to
learn an odor cue (orange scent) as either cocaine S- or alcohol S-
(Fig. 3a, b). The rats trained for alcohol S- were not subjected to
alcohol liquid diet, and thus trained and tested under a non-
withdrawal state; this was done to isolate neural activity due to
omission cues from neural activity due to alcohol withdrawal
(e.g., ref. 52). Another group of rats was trained as the olfactory
control and exposed to the same odor without a scheduled con-
sequence (i.e., odor-habituation: Fig. 3c). For each training con-
dition, the rats were further randomly divided into two groups
deﬁned by the ﬁnal cue-condition and exposed to the odor (“S-”)
or no odor (“No S-”) for 90 min for optimal induction of Fos,
then deeply anesthetized and euthanized. Active lever, light-cue,
and drug reward were all withheld to determine neurons
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speciﬁcally reactive to S- (or No S-). Their brains were harvested
and processed for Fos IHC (Fig. 3d, e) to determine omission cue-
triggered neural activation in IL.
Extending the previous reports11,15,22, the odor cue (vs. no
odor cue), conditioned as cocaine S- or alcohol S-, signiﬁcantly
increased the numbers of Fos-positive (Fos+) cells in IL (Fig. 3g).
In contrast, an identical but non-conditioned and well-habituated
odor cue did not. The observed neural activity in IL (Fig. 3g) is
thus presumably due to the omission (learning) rather than
olfactory (sensory) property of the S- odor cue. Interestingly, the
odor cue increased Fos+ nuclei to similar extents in different
groups of rats trained for cocaine S- and alcohol S-, suggesting
that similar neuronal processes mediate the anti-relapse action of
S- across different classes of abused drugs.
To further examine this possibility, additional groups of rats
were trained for the same odor cue as cocaine S- (Fig. 3a) or
alcohol S- (Fig. 3b). The rats were exposed to the S- odor for 90
min, then deeply anesthetized and euthanized. Active lever, light-
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cue, and drug reward were all withheld to determine neurons
speciﬁcally reactive to S-. Their brains were harvested and
processed for RNAscope® (Fig. 3f) to determine omission cue-
activation across major cortical neural phenotypes. For this, each
IL section was probed for four types of messenger RNA (mRNA)
(encoding protein): c-fos (Fos), Slc17a7 (vesicular glutamate
transporter 1 [VGLUT1]), Slc32a1 (vesicular gamma-
aminobutyric acid transporter [VGAT]), and CHAT (choline
acetyltransferase [ChAT]), each as a marker for omission cue-
activated (S- reactive), glutamatergic (GLU), GABAergic (GABA),
and cholinergic (ACh) nuclei. Each nucleus was identiﬁed by
DNA-staining 4′,6-diamidino-2-phenylindole (DAPI) and used
as the “region of interest” (ROI) for phenotype identiﬁcation. On
average (± SEM), we analyzed 1946.2 (± 200.1) nuclei per animal
and conducted three lines of analyses.
First, we determined the overall extent of omission cue-
activation as well as the overall phenotypic compositions—
independent of S- reactivity—in IL (Fig. 3h). Consistent with the
results from Fos IHC (Fig. 3g), both cocaine S- and alcohol S-
induced similar levels of neural activation, as indicated by the
numbers of S- reactive (c-fos+) cells, in IL. The signiﬁcant
phenotypic majority in IL, independent of neural activity, is GLU
cells (~45%) with a small population of GABA cells (~5%) and a
miniscule population of ACh cells (~1%). The majority of the
remaining (“other”) cells are presumably non-neural glial cells
(~51%). Second, we determined the extent of omission cue-
activation within each phenotype (Fig. 3i). Both cocaine S- and
alcohol S- induced similar levels of neural activation in GLU
(8–10%), GABA (9–13%) and other (3–5%) cell types, but did not
induce any detectable activation in ACh cells (0%). Third, we
determined the phenotypic composition of omission cue-
activated IL neurons (Fig. 3j). IL neurons reactive to cocaine S-
or alcohol S- had similar phenotypic compositions: GLU
(90–94%), GABA (4–7%), and other (2–3%)—but not ACh
(0%)—cell types.
We also determined the extent of omission cue-activation, as
indicated by the numbers of S- reactive (c-fos+) nuclei, across
cortical layers I, II, III, and V/VI, based on ref. 53 (layer V and VI
were analyzed jointly; no layer IV in rats). This additional analysis
(Supplementary Fig. 3a, b, c) revealed that IL neurons reactive to
either cocaine S- or alcohol S- were present at similar levels across
layers II, III, and V/VI, but were sparse in layer I, known to
contain few neurons.
In summary, both cocaine S- and alcohol S- induced similar
degrees of neural activation in IL with similar phenotypic
composites—suggesting an overlapping anti-relapse mechanism
in this site. Thus, we next tested the hypothesis that drug-
omission cues suppress relapse by recruiting functional cellular
units of S- reactive neurons (neural ensembles and/or memory
engram cells) in IL.
Anti-relapse neurons in the infralimbic cortex. Fos-lacZ trans-
genic rats54 were trained under the OCIS procedure to learn an
olfactory cue (orange scent) as cocaine S- (Fig. 4a). The rats were
then randomly divided into four groups (“Group”), deﬁned by
disruption-cue (“S-” or “No S-”) and microinjection (“Daun02”
or “vehicle”) for neural activity-targeted inactivation41. Each rat
was ﬁrst exposed to either S- or No S- for 90 min and then
received a bilateral microinjection of Daun02 (2.0 µg/0.5 µl/side)
or vehicle (0.5 µl/side) into IL (Fig. 4b). Active lever, light-cue and
cocaine were all withheld to target neurons speciﬁcally reactive to
S- (or No S-). In Fos-lacZ rats, Daun02 (inactive compound) is
catalyzed into daunorubicin (cytotoxin) by beta-galactosidase
(enzyme) only in Fos+ “activated” cells, thereby triggering
apoptosis40. In contrast, Daun02 cannot be catalyzed into dau-
norubicin in “non-activated” cells lacking Fos/beta-galactosidase,
and no cellular disruption occurs.
Each rat then underwent the Discrimination tests to determine
the effects of neural activity-based ablation of omission cue-
reactive neurons on relapse-suppression (Fig. 4c, d). In the two
vehicle-treated groups (“No S- & vehicle” and “S- & vehicle”),
cocaine S- suppressed relapse-promotion by cocaine availability
cues (active lever and light-cue) and cocaine priming (20 mg/kg,
IP). In the group that received Daun02 without being exposed to
cocaine S- (“No S- & Daun02”), cocaine S- also suppressed such
relapse-promotion, and thus its anti-relapse action was preserved.
In contrast, in the group that received Daun02 following exposure
to cocaine S- (“S- & Daun02”), cocaine S- failed to suppress
relapse-promotion by cocaine availability cues and cocaine
priming. Thus, Daun02 disruption of omission cue-reactive
neurons in IL blocked the anti-relapse action of cocaine S-. For
all groups, inactive lever-pressing remained minimal during both
S- and No S- tests (Supplementary Fig. 4a, b).
For all cases, Daun02 disruption was veriﬁed by Fos IHC (Fig.
4e). For this, all rats were exposed to S- for 90 min, deeply
anesthetized and euthanized. Active lever, light-cue and cocaine
were all withheld to determine the neurons speciﬁcally reactive to
S-. Compared to the “No S- & vehicle”, “S- & vehicle”, and “No S-
& Daun02” groups, the “S- & Daun02” group exhibited
signiﬁcantly reduced numbers of Fos+ nuclei in IL. The fact that
the number of the remaining Fos+ cells in this group (25.5 ± 3.7
nuclei per mm2) is nearly identical to the corresponding number
Fig. 2 Omission cue-induced suppression (OCIS) procedure for alcohol seeking. All data are mean and SEM. Gray open circles depict individual data-points.
Thirty-three rats were initially used and randomly assigned to alcohol and stress priming groups (n= 15,18). Of which, 25 rats were retained for statistical
analyses (see Methods). Final Ns per group are described below. a Timeline and schedule. b Responses during the ﬁrst 10-days of Self-administration (SA)
training. c, d Responses during the last and ﬁrst 10 days of Discrimination training under non-withdrawal (NW) and acute withdrawal (AW) conditions.
Operant training was resumed 4–5 days following the diet schedule change to induce AW. n= 25. Two-way repeated measures ANOVA: Withdrawal
(F(1,24)= 18.27, P < 0.001) main effects. #P < 0.01–0.05 vs. NW. Tuckey HSD test. e Responses during the ﬁrst 1-h block of Discrimination test to
determine the anti-relapse action of alcohol S- against alcohol availability cues under NW, AW, and protracted withdrawal (PW). n= 25. Two-way
repeated measures ANOVA: Withdrawal (F(2,48)= 15.01, P < 0.001) and Cue-Test (F(1,24)= 120.78, P < 0.001) main effects, Withdrawal x Cue-Test
interaction (F(2,48)= 11.85, P < 0.001). #P < 0.01–0.05 vs. NW. *P < 0.001 vs. No S-. Tuckey HSD test. Duplicate data-points from multiple subjects are not
overlaid on this Figure for clarity because n= 25. Thus, the dot plots represent the data range. f Responses during the second and third 1-h blocks of
Discrimination test to determine alcohol S-‘s action against alcohol priming under NW, AW, and PW. n= 12. Three-way repeated measures ANOVA:
Withdrawal (F(2,22)= 13.22, P < 0.001) and Priming (F(1,11)= 97.50, P < 0.001) main effects, and Withdrawal x Priming (F(2,22)= 16.48, P < 0.001), Cue-
Test x Priming (F(1,11)= 24.22, P < 0.001) and Withdrawal x Cue-Test x Priming (F(2,22)= 14.78, P < 0.001) interactions. #P < 0.01–0.05 vs. NW. †P < 0.01
vs. water. *P < 0.01–0.05 vs. No S-. Bonferroni test. g Responses during the second and third 1-h blocks of Discrimination test to determine alcohol S-‘s
action against stress priming under NW, AW, and PW. n= 13. Three-way repeated measures ANOVA: Priming (F(1,12)= 27.65, P < 0.001), Withdrawal x
Priming (F(2,24)= 8.34, P < 0.01), Cue-Test x Priming (F(1,12)= 17.70, P < 0.01), and Withdrawal x Cue-Test x Priming (F(2,24)= 6.20, P < 0.01) interactions.
#P < 0.05 vs. NW. †P < 0.01 vs. saline. *P < 0.05 vs. No S-. Bonferroni test
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in the “no odor cue” controls (23.2 ± 5.1 nuclei per mm2: see Fig.
3g) suggests that these remaining Fos+ cells likely represent a
random set of spontaneously active cortical neurons.
In summary, activity-based ablation of omission cue-reactive
IL neurons by Daun02 prevented relapse-suppression.
Discussion
Under the OCIS procedure, drug-omission cues suppressed the
three major modes of relapse-promotion (drug-predictive cues,
stress and drug priming)3 across two major classes of abused
drugs (cocaine and alcohol) in male rats. These anti-relapse
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actions were observed under laboratory conditions (extensive
drug access and withdrawal) linked to compulsive drug use18,19
and heightened relapse risk20,21. The present results thus support
the translational relevance of the OCIS procedures as an animal
model to investigate the neurobehavioral processes against
relapse.
The anti-relapse action of drug omission cues (also see
refs. 10,11,13,14,17,43) is presumably mediated by a learning process
similar to “conditioned inhibition”8 or “negative occasion set-
ting”9 and is distinct from “extinction” of operant responding for
relapse-promoting availability cues. Consistent with this pre-
sumption, the OCIS procedure was effective against stress (foot-
shock and yohimbine) and drug priming (cocaine and alcohol)
known to reinstate drug seeking even after extensive extinction
training3. Similar actions of drug omission cues have been
reported11,17,43. Reminiscent of these differences between OCIS
and extinction, omission cues without a history of strong exci-
tatory conditioning (such as the odor stimulus in the current
study) are reportedly capable of suppressing unconditioned
responses (e.g., fear response triggered by brain electric stimula-
tion); whereas, omission cues with a history of strong excitatory
conditioning (such as an extinguished drug-paired context) are
not55,56.
While response inhibition through extinction is environmental
context-speciﬁc57, response inhibition through similar omission
cue procedures for non-drug rewards can be preserved in dif-
ferent contexts58. Thus, the anti-relapse action of drug omission
cues may transcend the context-speciﬁcity and major limitation
of the cue-exposure therapies7 designed to extinguish relapse-
promoting cues through extinction training. Indeed, omission
cue-training has been applied in humans to suppress learned
responses, such as conditioned fear response59–61. However, the
clinical application of the OCIS procedure is likely limited due to
the difﬁculty of contrasting drug access with no-access conditions
(discrimination training) extensively.
Nevertheless, the OCIS procedure provides a behavioral plat-
form to study the brain processes that actively suppress—rather
than promote—drug seeking, craving, and relapse. A particular
advantage of OCIS over extinction is that the inhibition of
learned drug responses is controlled by a single cue, uniquely
associated with drug omission. In contrast, the response inhibi-
tion through extinction is controlled by an extinguished drug-
paired context, the composite of multiple drug omission cues,
which originally signaled drug availability. Unlike such extinction
incorporated into standard reinstatement procedures, the
extinction under the “ABA renewal” procedure57,62 shares simi-
larities with OCIS. This type of extinction is established in a
strictly non-drug-paired—thus “omission”—context (“Context
B”), which is distinct from the context (“Context A”) in which
operant drug response is initially established. Such omission
context has been shown to block the relapse-promoting action of
drug (alcohol) priming16. However, several procedural differences
exist between the ABA renewal and OCIS, such as the use of (1)
singular (ABA) vs. repetitive (OCIS) contrasting between drug
availability and drug omission conditions and (2) compound
(ABA) vs. simple (OCIS) stimuli to signal drug omission. Whe-
ther such differences inﬂuence relapse-suppression and corre-
sponding brain processes still needs to be elucidated. Finally,
unlike under the “conditioned suppression” (e.g., ref. 19) or
“punishment” (e.g., ref. 18) procedures, the conditioned stimulus
to inhibit learned responses is not coupled with an aversive event
(e.g., electric foot-shock) under the OCIS procedure. In summary,
the relative simplicity of the OCIS procedures makes it more
straightforward to determine the relationship between a speciﬁc
brain process and relapse-suppression.
The OCIS of drug seeking is, in part, mediated by omission
cue-reactive neurons in IL. In this brain region implicated in
decision making and impulse control26,27, cocaine and alcohol
omission cues induced similar levels of neural activation and
recruited neurons with similar phenotypic characteristics. While
addiction to cocaine and alcohol are marked by some overlapping
but also each distinct mechanisms63, a similar neuronal process
may therefore underlie learned suppression of drug seeking across
different drug classes.
The observed neural activation in IL is likely caused by
omission cue-triggered release of glutamate, which is the primary
source of cortical excitation64. Glutamatergic inputs to IL origi-
nate from diverse brain sites65, including the hippocampus, the
thalamus, the hypothalamus, and the amygdala. Additionally, IL
receives cholinergic inputs, which also excite cortical neurons,
from the basal forebrain and the brainstem65. Other neuro-
transmitters (e.g., dopamine and serotonin) and peptides (e.g.,
endogenous opioids and neurotensin) in IL66 can also modulate
cortical excitability. Thus, OCIS may be processed through an
ensemble of multiple afferent circuits and neurochemicals, rather
than a speciﬁc projection or transmitter.
Within IL, omission cue-reactive neurons were concentrated
in layers II, III, and V/VI, but were sparse in layer I. The
predominant omission cue-reactive neural phenotype was
glutamatergic and thus presumably cortical pyramidal neu-
rons. These excitatory cells constitute the majority of cortical
neurons30 and project to other cortical and subcortical sites67.
Within the glutamatergic population, sizable subsets (~10%)
were omission cue-reactive; thus, OCIS may be processed
through an ensemble of multiple omission cue-reactive efferent
circuits, rather than a singular projection. Sizable subsets
Fig. 3 Omission cue-induced suppression (OCIS) procedures for localization and phenotypic characterization of omission cue-reactive neurons in IL. All
data are mean and SEM. Gray open circles on bar charts depict individual data-points. a, b, c Timeline and schedule. d Target sites (line drawings adapted
from Paxinos and Watson81 with permission). e, f Representative sections. g Effects of cocaine S-, alcohol S-, and well-habituated odor on neural activation
in IL as indicated by Fos immunohistochemistry. n= 10,9,8,9,6,6. Two-way between-subjects ANOVA: Training (F(2,42)= 4.81, P < 0.05) and Cue-Test
(F(1,42)= 28.67, P < 0.001) main effects, and Training x Cue-Test interaction (F(2,42)= 3.77, P < 0.05). *P < 0.001 vs. No S-. Tuckey HSD test. h, i, j Neural
phenotypes in IL reactive to cocaine or alcohol S- as indicated by in situ hybridization via 4-plex RNAscope® targeting c-fos, Slc17a7, Slc32a1, and CHAT, as
markers for “S- reactive”, “glutamatergic (GLU)”, “GABAergic (GABA)”, and “cholinergic (ACh)” nuclei. Each nucleus was identiﬁed by DAPI. For statistical
analyses, total numbers of nuclei per mm2 that satisﬁed each phenotypic criterion were used. For graphic representations, percentages of each phenotype
within a speciﬁc “parent” phenotype were used. h Percentages of different phenotypes within all DAPI-positive nuclei. n= 7,8,15. Individual data-points are
not overlaid on the right panel for clarity because n= 15. For this panel, data from rats tested for cocaine S- and alcohol S- were pooled to represent the
overall percentages of different phenotypes independent of neural activity. Two-way mixed ANOVA: Phenotype (F(4,52)= 532.79, P < 0.001), but not
Group (F(1,13)= 4.05, NS) or Group x Phenotype interaction (F(4,52)= 0.34, NS). n= 7,8. i Percentages of S- reactive nuclei within different phenotypes.
Two-way mixed ANOVA: Phenotype (F(3,39)= 38.62, P < 0.001), but not Group (F(1,13)= 2.5, NS) or Group x Phenotype interaction (F(3,39)= 1.74, NS). j
Percentages of different neural phenotypes within S- reactive nuclei. Two-way mixed ANOVA: Phenotype (F(3,39)= 27.77, P < 0.001), but not Group (F(1,13)
= 2.20, NS) or Group x Phenotype interaction (F(3,39)= 2.04, NS). n= 7,8
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(~13%) of GABAergic cells were also omission cue-reactive.
Presumably, these are inhibitory interneurons, which
form local circuits and gate cortical signal ﬂows31. Small
numbers of cholinergic cells, presumably interneurons32, were
also present but not recruited by either cocaine or alcohol
omission cues.
The relative contribution of each omission cue-reactive phe-
notype still needs to be determined. It is, however, tempting to
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Fig. 4 Omission cue-induced suppression (OCIS) procedures for functional characterization of omission cue-activated neurons via activity-based Daun02
disruption. All data are mean and SEM. Gray open circles on bar charts depict individual data-points. Tukey HSD test was used for all post-hoc analyses. a
Timeline and schedule. b Daun02 disruption sites (line drawings adapted from Paxinos and Watson81 with permission). c Responses during the ﬁrst 2-h
block of Discrimination test to determine cocaine S-‘s action against cocaine availability cues. n= 7,7,8,8. Two-way mixed ANOVA: Cue-Test (F(1,26)=
37.70, P < 0.01) main effects and Group x Cue-Test interaction (F(3,26)= 3.49, P < 0.05).*P < 0.001 vs. No S-. #P < 0.05. d Responses during the second
and third 2-h blocks of Discrimination test to determine anti-relapse action of cocaine S- against cocaine priming. Two-way repeated measures ANOVA
was separately conducted for each group. “No S- & vehicle” group (n= 7): Priming (F(1,6)= 7.50, P < 0.05) main effects and Cue-Test x Priming interaction
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Priming interaction (F(1,7)= 1.71, NS). †P < 0.001 vs. saline. *P < 0.01–0.05 vs. No S-. e Daun02 validation via Fos IHC. n= 7,7,8,8. One-way between-
subject ANOVA: Group (F(3,26)= 10.25, P < 0.01). *P < 0.05 vs. all other groups
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speculate that the inhibitory control of drug seeking is orche-
strated by excitatory efferent-ensembles of IL pyramidal cells,
which project to brain sites thought to regulate learned responses,
such as the basolateral amygdala68 and the nucleus accumbens
shell69. Meanwhile, inhibitory local circuit-ensembles of
GABAergic interneurons may have disrupted IL neurons that
normally promote relapse37. Unfortunately, no existing technique
allows for separate manipulation of neurons with different phe-
notypic characteristics (e.g., glutamatergic vs. GABAergic) based
on their intrinsic activity (e.g., cue-reactive vs. non-reactive) in
rats. Nonetheless, activity-based ablation of omission cue-reactive
neurons in IL by Daun02 blocked the OCIS of drug seeking,
thereby establishing the causality between omission cue-induced
neural activity and relapse-suppression.
Taken together, the present results indicate that omission cue-
reactive neurons in IL act as a functional cellular unit for relapse-
suppression and, therefore, as an anti-relapse neuronal ensemble.
This interpretation is consistent with the notion that IL is the
brain site responsible for the inhibitory control of not only drug
seeking but also learned responses in general69,70. However, the
existence of neurons reactive to drug-predictive (rather than
omission) contexts with the opposite relapse-promoting function
has been reported in the same IL cortex37 (also see refs. 38,71,72).
These seemingly contradictory but neural activity-speciﬁc results
may explain the mixed reports33,34 regarding medial prefrontal
cortical regulation of drug seeking and relapse, and caution the
use of non-activity-speciﬁc techniques to probe brain behavioral
functions. Electrophysiological evidence that different IL neurons
encode response execution and inhibition73 further conﬁrms the
importance of manipulating brain cells based on their intrinsic
activity in addition to other characteristics, such as locality and
phenotype.
However, such neural activity-based manipulations have also
produced seemingly contradictory results. In the current study,
Daun02 disruption of IL neurons reactive to cocaine omission
cues increased operant response. Paradoxically, in Pfarr et al.40,
Daun02 disruption of IL neurons reactive to alcohol availability
cues also increased operant response. These results were each
interpreted to attribute a single behavioral function—relapse-
suppression—to presumably two distinct units of IL neurons—
each reactive to cues signaling drug availability or omission,
thereby raising a concern regarding the “cue-speciﬁcity” of
Daun02 disruption in IL.
The numerous differences in the experimental design between
Pfarr et al.40 and the current study make straightforward com-
parison of these seemingly contradictory results difﬁcult. Never-
theless, in conjunction with our previous observations22,23,37,
these discrepancies may be explained by differences in the
environmental contexts in which Daun02 disruption was
achieved. In the current study, Daun02 disruption of IL neurons
reactive to cocaine omission cues (which inhibit behavior) was
achieved in a well-habituated behaviorally “neutral” context. In
Pfarr et al., Daun02 disruption of IL neurons reactive to alcohol
availability cues (which excites behavior) was achieved in an
“extinguished” alcohol-predictive context (which inhibits beha-
vior)40. These arrangements may have simultaneously disrupted
two distinct units of IL neurons, each exerting opposing beha-
vioral actions. Consistent with this assumption, Daun02 disrup-
tion of IL neurons reactive to an “extinguished” food-predictive
context (which inhibits behavior) increased—rather than
decreased—operant response, while Daun02 disruption of IL
neurons reactive to a “non-extinguished” food-predictive context
(which excites behavior) decreased operant response23. Similarly,
Daun02 disruption of IL neurons reactive to a “non-extinguished”
heroin-predictive context (which excites behavior) also decreased
operant response37. While further research is necessary, it appears
important to control all environmental stimuli, including the
background context for activity-based brain cell manipulations, to
establish the cue-speciﬁcity of brain behavioral function.
Using a similar behavioral procedure for non-drug rewards and
activity-based neural ablation by Daun02 in a behaviorally
“neutral” context, we have demonstrated that two distinct func-
tional units of neurons—each selectively responsible for the
opposing behavioral actions of availability and omission cues—
co-exist within IL22. While the co-existence of distinct neuronal
ensembles for relapse-promotion and relapse-suppression within
IL and other brain sites still needs to be elucidated, such dis-
sociation in the neurobiological regulation of appetitive behavior
may be exploited in the future for the development of medica-
tions to facilitate—if not mimic—the anti-relapse action of drug-
omission cues. Further studies of omission cue-reactive neuronal
ensembles, as well as ensemble-speciﬁc brain circuitry and neu-
rochemical processes, may advance current knowledge in addic-
tion medicine through functional characterization of “druggable”
targets for relapse prevention.
Methods
All experimental procedures were conducted in accordance with the National
Institutes of Health (USA) Guidelines for the Care and Use of Laboratory Animals
and approved by the Institutional Animal Care and Use Committees at University
of Maryland Baltimore School of Medicine and The Scripps Research Institute.
Subjects. A total of 227 male rats were used. Of these, 177 were Long Evans (LE)
and 50 were Fos-lacZ transgenic (on Sprague Dawley background)54. Long Evans
rats were purchased from Charles River, Inc. (Wilmington, MA). Fos-lacZ rats were
bred at The Scripps Research Institute, and genotyped by Laragen, Inc. (Culver
City, CA). Rats weighing 250–300 g at the start of experiments were housed in a
temperature and humidity-controlled room, maintained on a 12 h/12 h reverse
light/dark cycle. The rats were always trained and tested during the dark (active)
phase in dedicated operant conditioning chambers (“chamber”). Each chamber was
equipped with two retractable levers (one “active lever” and one “inactive lever”), a
“light-cue,” a pump, and either a liquid swivel system for cocaine or a drinking well
for alcohol. At all times, water and food were available ad libitum.
Surgery. The LE rats assigned to the OCIS procedure for cocaine seeking were
implanted with an intravenous catheter made of Micro-Renathane (Braintree
Science, Braintree, MA) for intravenous cocaine self-administration. All Fos-lacZ
rats were implanted with the same intravenous catheter as well as permanent
bilateral guide cannulae (22G; Plastics One, Roanoke, VA, USA) for the micro-
injection of Daun02 (4.0 µg/1.0 µl in phosphate-buffered saline containing 5%
dimethyl sulfoxide and polysorbated [Tween®] 80) or vehicle into the infralimibic
cortex (IL). The microinjection coordinates were anteroposterior+ 3.2 mm, med-
iolateral ± 0.6 mm, and dorsoventral −5.5 mm. Rats were allowed to recover at least
7 days before the start of the behavioral procedures. Daun02 was purchased from
Sequoia Research Products, Pangbourne, Berkshire, UK (Cat# SRP0400g).
Behavioral procedures. OCIS procedure for cocaine seeking: schematics and
timeline are depicted in Fig. 1a. This procedure consisted of three experimental
phases. At all times, insertion of active and inactive levers into an operant con-
ditioning chamber signaled the start of a once daily lever-pressing session con-
ducted under a ﬁxed ratio 1 schedule of reinforcement (FR1). A press on the active
lever resulted in a single intravenous delivery of cocaine (1.0 mg/kg) or saline. Each
delivery of cocaine or saline was paired with 20 s illumination of a light-cue sig-
naling a 20 s time-out period, during which presses on the active lever were
recorded but had no scheduled consequence. At all times, presses on the inactive
lever were recorded but without a scheduled consequence. Each rat was housed in a
dedicated operant conditioning chamber (habituation) to minimize the neurobe-
havioral impact of environmental stimuli other than those manipulated
experimentally.
In summary, a total of 63 rats were initially used to determine the anti-relapse
action of cocaine S- (Fig. 1). These rats were randomly assigned to four
experimental groups: Compulsivity test, Cocaine (1.0 or 2.0 mg/kg) and Stress
priming groups (n= 14,16,16,17). Of these, 18 rats were excluded from the study:
three rats died during the intravenous surgery, three rats died due to post operation
complications, and 12 rats lost the intravenous catheter patency before completing
the entire experimental schedule and/or failed to satisfy the preset training criteria
(see below). A total of 45 rats were thus retained for the ﬁnal statistical analyses and
graphic representations (see below).
Detailed procedures for each experimental phase are described below:
I. Self-administration training (2–3 weeks): the purpose of this phase was to
establish [1] operant responses for cocaine and [2] active lever and light-cue as
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“cocaine availability cues”. All rats were trained to press an active lever for cocaine
presented together with a light cue in once daily 4-h operant conditioning sessions.
Rats were required to satisfy the following training criteria: [1] a minimum of
2 weeks of cocaine self-administration and [2] a minimum of 30 cocaine injections
for 3 consecutive days. Rats that did not satisfy these criteria within 3 weeks of
training were excluded. During this phase, the active lever and light-cue came to
predict the availability of cocaine and thereafter served as cocaine-predictive
“availability cues” for the remaining experiments.
II. Discrimination training (9–12 weeks): the purpose of this phase was to
establish a discriminative stimulus predictive of cocaine omission (S-). The rats
were trained to recognize an olfactory cue as S-. Each rat underwent alternating
once daily cue-training sessions: [1] “No S- training” (active lever-pressing for
cocaine and light-cue in the absence of an orange scent) and [2] “S- training”
(active lever-pressing for saline—instead of cocaine—and light-cue in the presence
of an orange scent). Each training session lasted for 2 h. The orange scent was
provided by placing a Petri dish with gauze soaked with 3.0 ml of orange extract
(McCormick® Orange Extract, McCormick & Company, Sparks, MD, USA) inside
each chamber, starting 30 min prior to and remaining throughout each session. For
No S- sessions, 3.0 ml of water was used instead of the orange extract. Rats were
required to satisfy the following criteria: [1] a minimum of 9 weeks of
Discrimination training, [2] a minimum of 15 cocaine injections across three
consecutive No S- sessions, and [3] a maximum of ﬁve saline injections across three
consecutive S- sessions. Rats that did not satisfy these criteria within 12 weeks of
training were excluded.
III. Discrimination tests (2 days): the purpose of this phase was to test the anti-
relapse action of cocaine S-. The rats were randomly assigned to one of three
experimental groups deﬁned by the type of priming used: minor electric foot-shock
stress or 10 or 20 mg/kg of IP cocaine. Each rat underwent two types of once daily
cue-test sessions: [1] “No S- test” (active lever-pressing for saline—instead of
cocaine—and light-cue in the absence of an orange scent) and [2] “S- test” (active
lever-pressing for saline and light-cue in the presence of an orange scent). The
order of S- and No S- tests were randomly counterbalanced between subjects. Each
test session lasted for 6 h and was divided into three 2-h blocks designed to
determine the anti-relapse action of S- against the relapse-promoting action of
cocaine availability cues (ﬁrst block), stress, or cocaine priming (second and third
blocks). As with the S- training sessions, the S- test session was preceded (by 30
min) and accompanied by orange scent. The anti-relapse action of S- against
cocaine availability cues (active lever and light-cue) was determined in all rats,
while the action against stress and cocaine priming (two different doses) was
determined in different groups of rats. Rats in one of the three experimental groups
received sham shock (no shock) and then stress priming (10 min of intermittent
electric foot-shock) at 2-h and 4-h into each session, respectively (within-session
reinstatement). Electric foot-shock (0.8 mA, 1-s) was delivered on a variable time
schedule at a mean interval of 40 s (10–70 s range). This stress priming procedure
was based on a previously developed protocol42. Rats in the remaining two groups
received a non-contingent IP injection of saline (0.5 ml) and then one of the two
priming doses of cocaine (10 or 20 mg/kg) at 2-h and 4-h into each session,
respectively. The orange extract or water was resupplied at 2-h and 4-h into each
session. The total number of active-lever presses for each 2-h block was used as the
dependent variable for statistical analysis.
Compulsivity test (Fig. 1d): the purpose of this additional experiment was to
determine whether the extended access to cocaine through the OCIS procedure
resulted in compulsive drug intake. Rats were trained under the OCIS procedure
for cocaine (Fig. 1). Half of these rats were tested following Self-Administration
training (2–3 weeks of cocaine history), while the remaining rats were tested
following Discrimination training (11+weeks of cocaine history). In the absence of
cocaine S-, each rat was allowed two once daily 2-h sessions to self-administer
cocaine under a FR1 schedule of reinforcement. Each self-administered cocaine
intravenous infusion was paired with a sham shock (0.0 mA) during the ﬁrst
“baseline” session and an electric foot-shock (0.8 mA, 1-s) during the second
session (adapted from ref. 18). The percent reduction in the number of self-
administered cocaine infusion (2-h totals) due to the foot-shock was used as a
measure of each animal’s resistance to punishment (an adverse consequence) or
“compulsivity”.
OCIS procedure for alcohol seeking: schematics and timeline are depicted in
Fig. 2a. This procedure consisted of eight experimental phases. At all times,
insertion of both active and inactive levers into an operant conditioning chamber
signaled the start of a once daily lever-pressing session under a FR1 schedule of
reinforcement. Animals were placed in the operant conditioning chamber for 60
min prior to the start of each session (habituation). A press on the active lever
resulted in a single 0.1 ml delivery of either alcohol (20%, v/v) or water into a
drinking well. This alcohol dose is known to support robust operant alcohol self-
administration without sucrose fading in Long Evans74 and Wistar75 rats. Each
delivery of alcohol or water was paired with 5 s illumination of the light-cue
signaling a 5-s time-out period, during which presses on the active lever were
recorded but without a scheduled consequence. At all times, presses on the inactive
lever were recorded but without a scheduled consequence. Each rat was maintained
on different diets during different experimental phases: standard lab chow (Phases
I–III & VII–VIII), alcohol liquid diet adapted from refs. 44,45,47 (Phase IV), and
then alcohol liquid diet alternating with alcohol-free liquid diet (Phases V–VI).
In summary, a total of 33 rats were initially used to determine the anti-relapse
action of alcohol S- (Fig. 2). Of these, 15 and 18 rats were randomly assigned
(purchased) to alcohol and stress priming groups, respectively. Of these, eight rats
failed to satisfy the preset training criteria (see below) and were excluded from the
study. A total of 25 rats were thus retained for the ﬁnal statistical analyses and
graphic representations.
Before undertaking the OCIS procedure for alcohol (below), all rats were ﬁrst
acclimated to alcohol by receiving concurrent access to two drinking bottles,
containing 20% (v/v) alcohol (in water) or plain water, in their home cages for 3 to
4 weeks (adapted from ref. 50). This was to facilitate operant learning for alcohol.
The water bottle was always available, while the alcohol bottle was available
intermittently (every other day).
I. Self-administration training (4–5 weeks): the purpose of this phase was to
establish [1] operant responses for alcohol and [2] active lever and light-cue as
“alcohol availability cues”. All rats were trained to press an active lever for alcohol.
Each training session lasted for 14 h during the ﬁrst week and then for 1 h during
the remaining weeks. During the ﬁrst week, the rats underwent three training
sessions over 5 days (Mon–Fri); each 14-h session was conducted every other day.
Thereafter, the rats were trained 1 h daily. Training criteria: a minimum of 4 weeks
of training and a minimum of 20 alcohol deliveries per session for 3 consecutive
days. Rats failing to satisfy these criteria within 5 weeks were excluded.
II. Discrimination training NW (8–11 weeks): the purpose of this phase was to
establish a discriminative stimulus predictive of alcohol omission (S-) under a non-
withdrawal (NW) state. The rats were trained to recognize an olfactory cue as S-.
Each rat underwent alternating once daily cue-training sessions: [1] “No S-
training” (active lever-pressing for alcohol and light-cue in the absence of an
orange scent) and [2] “S- training” (active lever-pressing for water—instead of
alcohol—and light-cue in the presence of an orange scent). Each training session
lasted for 1 h. The orange scent was provided by placing a Petri dish with gauze
soaked with 3.0 ml of an orange extract (McCormick® Orange Extract, McCormick
& Company, Sparks, MD, USA) inside each chamber starting 30 min prior to and
remaining throughout each session. For No S- training, 3.0 ml of water was used
instead of the orange extract. Rats were required to satisfy the following criteria: [1]
a minimum of 8 weeks of Discrimination training, [2] a minimum of 20 alcohol
deliveries for three consecutive No S- session,s and [3] a maximum of ﬁve water
deliveries for three consecutive S- sessions. Rats that did not satisfy these criteria
within 11 weeks of training were excluded.
III. Discrimination tests NW (2 days): the purpose of this phase was to test the
anti-relapse action of alcohol S- under a non-withdrawal state (NW). The rats were
randomly assigned to one of two experimental groups deﬁned by the type of
priming used: the pharmacological stressor yohimbine or alcohol. Each rat
underwent two types of once daily cue-test sessions: [1] “No S- test” (active lever-
pressing for water —instead of alcohol—and light-cue in the absence of an orange
scent) and [2] “S- test” (active lever-pressing for water and light-cue in the presence
of an orange scent). The order of S- and No S- tests were randomly
counterbalanced between subjects. Each test session lasted for 3 h and was divided
into three 1-h blocks designed to determine the anti-relapse action of S- against the
relapse-promoting action of availability cues (ﬁrst block), as well as stress or
alcohol priming (second and third blocks). As with the S- training sessions, the S-
test session was preceded (by 30 min) and accompanied by orange scent. The anti-
relapse action of S- against availability cues (active lever and light-cue) was
determined in all rats, while the action against stress and alcohol priming were
determined in different groups of rats. Rats in the stress priming group received
non-contingent intraperitoneal injections of saline (0.5 ml) and then yohimbine
(0.75 mg/kg, adapted from ref. 51) at 1-h and 2-h into each session, respectively.
Rats in the alcohol priming group received a non-contingent delivery of water (0.2
ml) and then alcohol (0.2 ml, 20%, v/v, adapted from ref. 50) into the drinking well
at 1-h and 2-h into each session, respectively. Prior to the delivery of water or
alcohol priming, any remaining ﬂuid (water) in the drinking well was cleared by
the experimenter. The orange extract or water was resupplied at 1-h and 2-h into
each session. The total number of active-lever presses for each 1-h block was used
as dependent variables for statistical analysis.
IV. Dependence induction (3 weeks): the purpose of this phase was to induce
alcohol dependence via alcohol liquid diet. All rats were maintained on continuous
(24 h; 7 days/weeks) alcohol liquid diet consisting of alcohol (10%, v/v), Boost®
nutritional supplement (Nestle USA, Rosslyn, VA, USA), as well as vitamins and
minerals (adapted from refs. 44,45).
V. Discrimination training AW (3–5 weeks): the purpose of this phase was to
establish alcohol S- under an acute withdrawal (AW) state. All rats were subjected to
the experimental procedures for Discrimination training NW while undergoing
acute withdrawal from alcohol. For this, alcohol-free liquid diet (sucrose replacing
alcohol to equalize caloric content) was substituted for alcohol liquid diet for 10 h
daily. The ﬁrst operant training session was resumed 4–5 days after this diet
schedule change. Each training session was conducted 5–9 h into alcohol withdrawal
—a time window associated with physical and affective signs of withdrawal as well
as with elevated alcohol intake in dependent rats44,48,76–78. Rats were required to
satisfy the following criteria: (1) a minimum of 3 weeks of training, (2) a minimum
of 20 alcohol deliveries for three consecutive No S- sessions, and (3) a maximum of
ﬁve water deliveries for three consecutive S- sessions. Rats that did not satisfy these
criteria within 5 weeks of training were excluded.
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VI. Discrimination tests AW (2 days): the purpose of this phase was to test the
anti-relapse action of alcohol S- under an acute withdrawal (AW) state. All rats
were subjected to the experimental schedules for Discrimination Tests NW while
undergoing acute withdrawal from alcohol. Each testing session was conducted
5–9 h into alcohol withdrawal.
VII. Protracted withdrawal (2 weeks): the purpose of this phase was to induce
protracted withdrawal (PW). All rats were maintained on standard lab chow and
had no access to alcohol in their home cages.
VIII. Discrimination tests PW (2 days): the purpose of this phase was to test the
anti-relapse action of alcohol S- under a protracted withdrawal (PW) state. All rats
were subjected to the experimental schedules for Discrimination Tests NW at
2 weeks into alcohol withdrawal —a time period associated anxiety-like behavior79
and elevated alcohol intake77.
Localization and phenotypic characterization of omission cue-activated neurons
in IL: Rats were randomly assigned to two experimental groups (Fig. 3a, b) and
trained under the OCIS procedure to learn an olfactory stimulus (orange scent) as
either cocaine S- or alcohol S-. The rats trained for alcohol S- were not subjected to
the dependent/post-dependent procedures and thus were both trained and tested
under a non-withdrawal state; this was done to isolate neural activity due to
omission cues from similar activity due to alcohol withdrawal. Additional rats were
habituated to the same olfactory stimulus (orange scent) for 7 days (90 min/day)
but were not subjected to the OCIS procedures; these rats never experienced either
cocaine or alcohol. All rats were placed in the operant conditioning chamber at
least for 60 min prior to the start of each training and testing session (habituation).
During Discrimination training, each rat was subjected to alternating once daily
sessions to pair “No S- and either cocaine or alcohol” and “S- and either saline or
water (i.e., no cocaine or no alcohol)”. We were concerned that this routine cycle
(the “No S-” training followed by the “S-” training, or vice versa) would result in
neural activity due to the “expectancy” or higher basal Fos expression independent
of the S- presentation during Discrimination test. The rats thus underwent a
“habituation” phase to break the cycle prior to Discrimination test. However, no
systematic data is available to determine whether this habituation was indeed
necessary. For Discrimination test, the rats were randomly divided into two groups
deﬁned by the ﬁnal cue-condition to induce Fos and exposed to the odor (“S-”) or
no odor (“No S-”) for 90 min (for optimal induction of Fos protein, as well as c-fos
mRNA by a “sustained” stimulus, see ref. 80), then deeply anesthetized with
isoﬂurane and sacriﬁced to harvest brains for Fos IHC and RNAscope®. For Fos
IHC (Fig. 3e), the brains were perfused with 0.1 M phosphate-buffered saline
followed by 4% paraformaldehyde in 0.1 M sodium phosphate (pH 7.4), removed,
and cut into 40 μm thick coronal sections. For ﬂuorescence in situ hybridization via
RNAscope® (Fig. 3f), the brains were “ﬂash frozen” in isopentane, removed, and
cut into 10 μm thick coronal sections. For all cases, active lever, light-cue and drug
reward (cocaine or alcohol) were withheld to determine neurons speciﬁcally
reactive to S- (or No S-).
In summary, a total of 81 rats were initially used to determine and characterize
omission cue-activated neurons (Fig. 3): 37 rats for cocaine S-, 32 rats for alcohol S-
, and 12 rats for the olfactory control. Of the rats assigned for cocaine S-, two rats
died during the intravenous surgery, one rat died due to post surgery
complications, seven rats failed to satisfy the preset training criteria or lost IV
catheter patency, and one rat (exposed to cocaine S- for RNAscope®) was excluded
as an outlier with unusually high c-fos expression (> 2 standard deviations of the
mean). Of the rats assigned for alcohol S-, seven rats failed to satisfy the preset
training criteria. A total of 63 rats were retained for the ﬁnal statistical analyses and
graphic representations (see below): 26 rats for cocaine S- (19 rats for Fos IHC and
7 rats for RNAscope®), 25 rats for alcohol S- (17 rats for Fos IHC and 8 rats for
RNAscope®), and 12 rats for the olfactory control (all for Fos IHC).
Functional characterization of omission cue-activated neurons in IL: Fos-lacZ
transgenic rats were trained under the OCIS procedure to establish an olfactory
stimulus (orange scent) as cocaine S- (Fig. 4a). Animals were placed in the operant
conditioning chamber at least for 60 min prior to the start of each training and
testing session (habituation). The rats were then randomly divided into four groups
(Group) deﬁned by cue (“S-” or “No S-”) and microinjection (“Daun02” or
“vehicle”) for neural activity-targeted disruption. For this, each rat was exposed to
either S- or No S- for 90 min, then received a bilateral microinjection of Daun02
(2.0 µg/0.5 µl/side) or vehicle (0.5 µl/side) into IL (Fig. 4b). Active lever, light-cue,
and cocaine were all withheld to target neurons speciﬁcally reactive to S- (or No S-).
Each rat was allowed to recover for 2 days in their home cages and then subjected
to Discrimination tests for cocaine S-, as described above. Daun02 disruption was
veriﬁed by Fos IHC. For this, all rats were exposed to S- for 90 min, deeply
anesthetized with isoﬂurane, and then perfused with 0.1 M phosphate-buffered
saline followed by 4% paraformaldehyde in 0.1 M sodium phosphate (pH 7.4).
Active lever, light-cue and cocaine were all withheld to determine the neurons
speciﬁcally reactive to S- (or No S-). The brains were removed, cut into 40 μm thick
coronal sections, and processed for Fos IHC (Fig. 4e).
In summary, a total of 50 rats were used to determine the anti-relapse neurons
in IL (Fig. 4). Of these, 16 rats were excluded from the study: four rats died during
either intravenous or intracranial surgery, three rats died due to post operation
complications, and nine rats failed to satisfy the preset training criteria or lost IV
catheter patency. An additional four rats were excluded based on the histological
veriﬁcation of the intracranial cannulae (see below). A total of 30 rats were thus
retained for the ﬁnal statistical analyses and graphic representations (see below).
Fos and β-galactosidase immunohistochemistry. The paraformaldehyde-ﬁxed
brains were sectioned and processed for Fos immunohistochemistry (IHC) and
quantiﬁed. For this, Fos antibody (1:2,000 dilution) from Cell Signaling Technology
(Cat# 2250S, Danvers, MA, USA; RRID: AB_2247211) was used. These sections
were developed using an ImmPRESS™ HRP (Peroxidase) Polymer Kit from Vector
Laboratories (Cat# MP-7451, Burlingame, CA, USA; RRID:AB_2631198) and
diaminobenzidine. β-galactosidase antibody (1:1000 dilution) from Santa Cruz
Biotechnology (Cat# sc-65670, Dallas, TX, USA; RRID:AB_831022). Additional
brain sections were processed for X-gal (5-bromo-4-chloro-3-indolyl β-D-galacto-
pyranoside) histochemistry to validate the presence of β-galactosidase. The X-gal
kit (Cat# XGAL-0100; RRID:AB_2631199) was purchased from Rockland Immu-
nochemicals Inc. (Pottstown, PA).
The histological procedures for Fos IHC were based on previously published
procedures22,37,40,41. For this, bright-ﬁeld images of IL were captured and digitized
using an EVOS microscope (ThermoFisher, Inc., Waltham, MA, USA). These
images were used for [1] histological veriﬁcation of the co-localization of Fos and
β-galactosidase (i.e., Fos-lacZ positive), [2] histological veriﬁcation of the
microinjection sites, and [3] histological quantiﬁcation of Fos-expressing nuclei.
Nuclei expressing Fos and/or β-galactosidase were counted using ImageJ (National
Institute of Health, Bethesda, MD, USA; RRID:SCR_003070). The threshold level
was set to detect moderately to darkly stained nuclei but not lightly stained nuclei.
We counted nuclei from sampling areas around the microinjection site from 3–5
coronal sections per rat. Average numbers of Fos-positive (Fos+) nuclei per mm2
calculated for each rat were used for statistical analyses and data representations.
Image capture and quantiﬁcation were conducted by an observer blind to the
experimental conditions. Two rats were excluded because their microinjection sites
were determined to be outside of IL. Two additional rats were excluded due to
necrosis in tissues surrounding the microinjection sites.
4-plex ﬂuorescence in situ hybridization via RNAscope®. The ﬂash frozen
brains were cut into 10 μm coronal sections, placed directly onto charged micro-
scope slides, stored at −20 ˚C, and processed in accordance with the user manuals
for RNAscope® Multiplex Fluorescent Reagent Kit v2 (Advanced Cell Diagnostics,
#323100-USM) and RNAscope® 4-plex Ancillary Kit for Multiplex Fluorescent
Reagent Kit v2 Technical Note (Advanced Cell Diagnostics, #323120-TN). Brieﬂy,
frozen sections were ﬁxed in neutral buffered formalin, dehydrated with ethanol,
and pretreated with hydrogen peroxidase and then protease digestion. Four dif-
ferent RNA-speciﬁc probes were applied (see below) and hybridized. To identify
and quantify different mRNAs, sections then underwent three separate
hybridization-ampliﬁcation steps and, ﬁnally, four separate signal development
steps for each unique ﬂuorophore–RNA complex.
On each brain section, we targeted four mRNA types (encoding protein): c-fos
(Fos), Slc17a7 (vesicular glutamate transporter 1 [VGLUT1]), Slc32a1 (vesicular
gamma-aminobutyric acid transporter [VGAT]), and CHAT (choline
acetyltransferase [ChAT])—each as the marker for omission cue-activated (S-
reactive), glutamatergic (GLU), GABAergic (GABA) and cholinergic (ACh) cells,
respectively—as well as DAPI—as the marker for DNA-expressing nuclei. All
mRNA probes were designed by Advanced Cell Diagnostics: c-fos (GenBank
accession # NM_022197.2: target region, 473–1497), Slc17a7 (GenBank accession #
NM_053859.2: target region, 529–11630), Slc32a1 (GenBank accession #
NM_031782.21: target region, 288–1666), and CHAT (GenBank accession
#NM_001170593.1: target region, 259–1141). Each probe was tagged with a unique
Opal™ ﬂuorophore from PerkinElmer, Inc. (Waltham, MA, USA): c-fos-Opal 690
(Cy5), Slc17a7-Opal 520 (FITC), Slc32a1-Opal 570 (Cy3), CHAT-Opal 620 (Texas
Red), and DAPI.
Fluorescent images of the brain sections for RNAscope® were captured using
ZEISS LSM 710 and 780 laser scanning confocal microscopes with ZEN image
software (Carl Zeiss, Oberkochen, Germany). These systems are capable of
continuous spectral detection with seven lasers (405, 458, 488, 514, 561, 594, 633)
and a fully tunable (within 10 nm intervals) Quasar multi-channel system. Images
were saved as 64-bit TIFF ﬁles and analyzed by Image-Pro Premier software
(Media Cybernetics, Rockville, MD, USA). These images were used to determine
the percentages of [1] c-fos+ (S- reactive), Slc17a7+ (GLU), Slc32a1+ (GABA),
and CHAT+ (ACh) phenotypes within DAPI+ nuclei (Fig. 3h), [2] c-fos+ (S-
reactive) phenotypes within Slc17a7+ (GLU), Slc32a1+ (GABA), and CHAT+
(ACh) nuclei (Fig. 3i), and [3] Slc17a7+ (GLU), Slc32a1+ (GABA), and CHAT+
(ACh) phenotypes in c-fos+ (S- reactive) nuclei—all localized in IL (Fig. 3d).
To identify each mRNA signal, we used brain sections taken from the same
animals, but prepared without any probe as the negative control, to set the
threshold for background signals (noise), such as the natural auto-ﬂuorescence
activity. We used DAPI+ nuclei within IL as the “region of interests” (ROIs) to
identify and quantify each neural phenotype. On average (± SEM), we analyzed
1946.2 ( ± 200.1) ROIs (DAPI+ nuclei) per animal. Within each ROI (single DAPI
+ nucleus), we used correlation coefﬁcients (ratios between [1] co-localized area of
DAPI and a speciﬁc gene target and [2] the total area of each DAPI-expressing
nucleus) as the basis to identify each phenotype. Speciﬁcally, we applied a 25% or
greater correlation coefﬁcients between (1) DAPI and c-fos, (2) DAPI and Slc17a7,
(3) DAPI and Slc32a1, or (4) DAPI and CHAT signals as the criteria for (1) S-
reactive, (2) GLU, (3) GABA, and (4) ACh phenotypes. These criteria were used to
minimize “false positives” due to background (e.g., auto-ﬂuorescence), non-
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speciﬁcity (e.g., unspeciﬁc bindings due to staining or manufacture mistakes), or
imaging limitation (e.g., it is not possible to separate Slc17a7 signals on a GLU cell
body from Slc17a7 signals on GLU pre-synaptic terminals without using an
electron microscope). We also took account of the fact that c-fos mRNA can be
transiently expressed by any neuron (or even non-neural astrocytes) in response to
any stimulus—external (e.g., cage change) or internal (e.g., circadian surge in
metabolic signals, such as leptin)—other than an experimentally-manipulated
stimulus (e.g., S-) at any given time. We ﬁnally validated these criteria visually on
each brain section. For example, we conﬁrmed that the average correlation
coefﬁcient (± SEM) between DAPI and c-fos for all remaining DAPI+ nuclei,
which did not satisfy the preset criterion (> 25%) for the “S- reactive” phenotype,
was 0.09% (± 0.01%).
For data analysis (see below), total numbers of nuclei per mm2 that satisﬁed
each phenotypic criterion were used. For the graphic representations to depict the
phenotypic composites of omission cue-activated neurons in IL, percentages (%) of
each phenotype within a speciﬁc “parent” phenotype were used: % of c-fos+
/Slc32a1+/Slc32a1+/CHAT+ /unclassiﬁed (RNAscope signal negative) nuclei
within all DAPI+ nuclei (Fig. 3h: % of S- reactive/GLU/GABA/Ach/other cells
within all cells), % of c-fos+ nuclei within Slc32a1+/Slc32a1+/CHAT+/unclassiﬁed
nuclei (Fig. 3i: % S- reactive cells within GLU/GABA/Ach/other cells), and % of
Slc32a1+/Slc32a1+/CHAT+/unclassiﬁed nuclei within c-fos+ nuclei (% of GLU/
GABA/Ach/other cells within S- reactive cells).
Statistical analysis. For all cases, parametric statistical analyses were used. When
appropriate, analysis of variances (ANOVAs) were followed by post-hoc Tukey
honestly signiﬁcant difference (HSD) or Bonferroni test. For all cases, differences
were considered signiﬁcant when P < 0.05 (two-tailed). As our multifactorial
ANOVA yielded multiple main and interaction effects, we only report signiﬁcant
effects that are critical for data interpretation. No statistical methods were used to
predetermine sample sizes, but our sample sizes were similar to those reported in
the relevant literature. Data distribution was assumed to be normal, but this was
not formally tested. We used SigmaPlot/SigmaStat version 12.5 (Systat Software,
San Jose, CA, USA) and IBM SPSS Statistics 23 and 25 (IBM Corporation, Armok,
NY, USA).
OCIS procedure for cocaine: the behavioral procedures for the initial 2-h block
of each 6-h session of Discrimination test were identical across the three
experimental groups (stress, 10 or 20 mg/kg cocaine priming groups) designated to
establish the anti-relapse action of cocaine S- (Fig. 1e). Thus, the initial 2-h totals of
active lever-presses were pooled together and analyzed by Student’s t-test for
repeated measures (paired) with discrimination cue or “Cue-test” (two levels: S- vs.
No S-) as within-subjects factor. The second and third 2-h totals of active-lever
presses (within-session reinstatement) were analyzed within each group by two-
way ANOVA for repeated measures with Cue-test (two levels) and relapse-
promoting stimulus or “Priming” (two levels: no priming [no shock or saline] or
priming [mild foot-shock, 10 or 20 mg/kg of cocaine]) as within-subjects factors
(Fig. 1f, g, h). The results of Compulsivity tests were analyzed using Student’s t-test
(non-paired) with cocaine self-administration history (two levels: 2+weeks and
12+ weeks) as between-subjects factor (Fig. 1d).
OCIS procedure for alcohol: the total active lever-presses during Discrimination
training NW (last 5 “No S-” sessions) and Discrimination training AW (ﬁrst 5 “No
S-” sessions) were analyzed together by two-way ANOVA for repeated measures
with withdrawal state or “Withdrawal” (two levels) and training session or
“Session” (ﬁve levels) as within-subjects factors (Fig. 2c, d). The behavioral
procedures for the initial 1-h block of each 3-h Discrimination test were identical
for the two experimental groups (stress and alcohol priming) designated to
establish the anti-relapse action of alcohol S- (Fig. 2e). Thus, the initial 1-h totals of
active lever-presses were pooled together and analyzed by two-way ANOVA for
repeated measures with alcohol withdrawal state or “Withdrawal” (three levels:
non-withdrawal [NW], acute withdrawal [AW] and protracted withdrawal [PW])
and discrimination cue or “Cue-test” (two levels: S- and No S-) as within-subjects
factors. The second and third 1-h totals of active-lever presses (within-session
reinstatement) were analyzed within each group by three-way ANOVA for
repeated measures with Withdrawal (three levels), Cue-test (two levels) and
relapse-promoting stimulus or “Priming” (two levels: no priming [saline or water]
or priming [yohimbine or alcohol]) as within-subjects factors.
Localization and phenotypic characterization of omission cue-activated neurons
in IL: the Fos IHC results (Fos+ nuclei per mm2) to determine omission cue-
induced neural activation in IL (Fig. 3g) were analyzed by two-way ANOVA with
training group or “Group” (three levels: cocaine S-, alcohol S- and olfactory control
[Fig. 3a–c]) and cue-test conditions or “Cue-Test” (two levels: S-/odor cue vs. No
S-/No odor cue) as between-subjects factors. Initial observations under the
microscope revealed that layer I contained little to no Fos+ nuclei. This
observation was systematically conﬁrmed by additional analyses to determine S-
reactive nuclei in different cortical layers via RNAscope® (see below). The
subsequent Fos IHC as well as RNAscope® analyses were thus focused on layers II,
III, and V/VI.
RNAscope® results (c-fos+/Slc17a7+/Slc32a1+/CHAT+/unclassiﬁed nuclei per
mm2), for determining S- reactive, GLU, GABA, ACh, and “other” phenotypes
from rats trained for cocaine S- vs. alcohol S- (Fig. 3h), were analyzed by two-way
mixed ANOVA with training group or “Group” (two levels: cocaine S- and alcohol
S-) as between-subjects factor and cellular phenotype or “Phenotype” (ﬁve levels)
as within-subjects factor. RNAscope® results (c-fos+ nuclei within Slc17a7+
/Slc32a1+/CHAT+/unclassiﬁed nuclei per mm2), for determining S- reactive
nuclei within GLU, GABA, ACh, and other phenotypes from rats trained for
cocaine S- vs. alcohol S- (Fig. 3i), were analyzed by two-way mixed ANOVA with
Group (two levels) as between-subjects factor and Phenotype (four levels) as
within-subjects factor. RNAscope® results (Slc17a7+/Slc32a1+/CHAT+
/unclassiﬁed nuclei within c-fos+ nuclei per mm2), for determining GLU, GABA,
ACh, and other phenotypes within S- reactive nuclei from rats trained for cocaine
S- vs. alcohol S- (Fig. 3j), were also analyzed by two-way mixed ANOVA with
Group (two levels) as between-subjects factor and Phenotype (four levels) as
within-subjects factor.
Additional RNAscope® analyses were conducted to determine the expression of
cocaine S- or alcohol S- reactive IL nuclei across different cortical layers
(Supplementary Fig. 3). For this, the numbers of c-fos+ nuclei per mm2 within
layers I, II, III, and V/VI were determined. These results were analyzed by two-way
mixed ANOVA with Group (two levels) as between-subjects factor and cortical
layers (four levels: layers V and VI were jointly analyzed) as within-subject factor.
Please note: these cortical layer analyses were conducted using additionally
processed sections from the same subjects included in the results depicted in Fig. 3
(seven rats for cocaine S- and eight rats for alcohol S-). This resulted in slight
variations in S- reactivity (the percentages of c-fos+ nuclei within DAPI+ nuclei)
within the same Group (cocaine S- or alcohol S-) between the results depicted in
Fig. 3 and Supplementary Fig. 3.
Functional characterization of omission cue-activated neurons in IL: the initial
2-h totals of active lever-presses were analyzed by two-way mixed ANOVA with
experimental group or “Group” (four levels: “No S- & vehicle”, “No S- & Daun02”,
“S- & vehicle”, “S- & Daun02”) as between-group factor and discrimination cue or
“Cue-test” (two levels: “S-” vs. “No S-”) as within-subjects factor (Fig. 4c). The
second and third 2-h totals of active-lever presses (within-session reinstatement)
were analyzed separately for each Group (four separate analyses) by two-way
ANOVA for repeated measures with Cue-test (two levels) and Priming (two levels)
as within-subject factors. The Fos IHC results, for validating the Daun02 disruption
of S- reactive neurons, were analyzed by one-way ANOVA with Group (four levels)
as between-group factor (Fig. 4e).
Data availability
The data that support the ﬁndings of this study are available from the corresponding
authors upon reasonable request.
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